Company News

The 2024 semi-annual summary meeting of the Group was successfully held

  On August 31, 2024, the semi-annual work conference of Qingdao Jiulong Biomedical Group was successfully held at the group headquarters. Liu Naishan, founder and chairman of the Group, made a report entitled "Focus on expanding the two major markets at home and abroad, continue to improve and strengthen the complete industrial chain, accelerate the development of new quality productivity, and solidly promote high-quality development including listing". Song Jianwen, former director of the Standing Committee of the West Coast New District of Qingdao, attended the meeting and gave a speech. Qu Shiye, chief engineer of the group, attended the meeting and gave a speech. The meeting was presided over by the executive manager Du Jingu.

The 2024 semi-annual summary meeting of the Group was successfully held

  The 2024 semi-annual summary meeting of the Group was successfully held

  At about 8:30 a.m., the meeting opened with the high song of Kangwon.

  In the report, the chairman summarized the work of the first half of the year, analyzed the existing problems and deficiencies, made the deployment of the work arrangement for the second half of the year, and called all the members of the group to work hard to complete the annual goals and tasks.

  In the first half of the year, with high-quality development as the main line, the Group promoted the steady growth of the production quantity and quality of the two major businesses of raw materials and preparations, the steady improvement of sales expansion, the solid progress of research and development work, the breakthrough progress of the industrial chain construction, and the improvement of the "scientific, institutional and standardized" construction within the enterprise, which was closer to the listing goal.

  In the second half of the year, the HCG, HMG and UK urine of Kangyuan will achieve the goal of stable quantity and quality, Guanlong will continue to ensure the high-quality supply of centralized procurement products, and Kowloon will go all out to re-establish its position as the main force of revenue. At the same time, sales work and research and development work will be further increased, and the chain strengthening, chain supplement and chain extension work will continue to be implemented.

  At the meeting, a total of 12 people who are mainly responsible for managers and sales, production and other major business managers of companies and branches made statements.

  At 11:50, the group's half-year working conference closed successfully.